CA2528095C - Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation - Google Patents

Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation Download PDF

Info

Publication number
CA2528095C
CA2528095C CA2528095A CA2528095A CA2528095C CA 2528095 C CA2528095 C CA 2528095C CA 2528095 A CA2528095 A CA 2528095A CA 2528095 A CA2528095 A CA 2528095A CA 2528095 C CA2528095 C CA 2528095C
Authority
CA
Canada
Prior art keywords
methods
compositions
making
pathogenic microorganisms
inactivating pathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2528095A
Other languages
English (en)
Other versions
CA2528095A1 (fr
Inventor
James R. Baker
Ted C. Annis
Tarek Hamouda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanobio Corp
Original Assignee
Nanobio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobio Corp filed Critical Nanobio Corp
Publication of CA2528095A1 publication Critical patent/CA2528095A1/fr
Application granted granted Critical
Publication of CA2528095C publication Critical patent/CA2528095C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention a trait à des compositions de nanoémulsions à faible toxicité présentant une inactivation d'une grande variété de micro-organismes ou de prévention de maladies. Les nanoémulsions contiennent une phase aqueuse, une phase huileuse, comprenant une huile et un solvant organique, et un ou des tensioactifs. L'invention a également trait à des procédés de fabrication de nanoémulsions et d'inactivation de micro-organismes pathogènes.
CA2528095A 2003-06-04 2004-06-03 Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation Expired - Lifetime CA2528095C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45763303P 2003-06-04 2003-06-04
US60/475,633 2003-06-04
PCT/US2004/017417 WO2005027872A2 (fr) 2003-06-04 2004-06-03 Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation

Publications (2)

Publication Number Publication Date
CA2528095A1 CA2528095A1 (fr) 2005-03-31
CA2528095C true CA2528095C (fr) 2014-10-14

Family

ID=34375188

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2528095A Expired - Lifetime CA2528095C (fr) 2003-06-04 2004-06-03 Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation

Country Status (4)

Country Link
EP (1) EP1633322A2 (fr)
AU (1) AU2004273779B2 (fr)
CA (1) CA2528095C (fr)
WO (1) WO2005027872A2 (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
WO2004100890A2 (fr) 2003-05-09 2004-11-25 The Trustees Of Columbia University In The City Of New York Procedes lies a la fonction rage g82s et compositions destinees au traitement de troubles inflammatoires
AU2016244292A1 (en) * 2005-07-18 2016-11-03 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
KR20130079645A (ko) 2005-07-18 2013-07-10 유니버시티 오브 메사츄세츠 로웰 나노에멀젼 조성물 및 이의 제조 및 사용 방법
CA2618974C (fr) 2005-08-09 2014-01-28 Nanobio Corporation Compositions de nanoemulsions possedant une activite anti-inflammatoire
CN101374498A (zh) 2005-12-01 2009-02-25 麻萨诸塞州洛厄尔大学 肉毒杆菌纳米乳液
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
AU2007240983A1 (en) * 2006-04-07 2007-11-01 Novavax, Inc. Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties
WO2007120860A2 (fr) * 2006-04-13 2007-10-25 The Regents Of The University Of Michigan Vaccins à base d'une nanoémulsion
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
FR2907012B1 (fr) * 2006-10-12 2012-09-21 Galderma Sa Composition dermatologique comprenant des nanocapsules d'avermectine, son procede de preparation et son utilisation
WO2008070538A2 (fr) 2006-12-01 2008-06-12 Anterios, Inc. Nanoparticules à entités amphiphiles
SG10201607909WA (en) 2006-12-01 2016-11-29 Anterios Inc Peptide nanoparticles and uses therefor
EP1938801A1 (fr) 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoémulsion
DE102007007698A1 (de) * 2007-02-09 2008-08-21 Exner, Heinrich, Dr. Verwendung einer hochemulgierten Silikonöl-Emulsion (HSE)zur Herstellung eines Medikamentes
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
US9144606B2 (en) 2008-04-21 2015-09-29 Nanobio Corporation Nanoemulsion influenza vaccine
WO2009132342A1 (fr) * 2008-04-25 2009-10-29 Nanobio Corporation Nanoemulsions destinées à traiter des infections fongiques, et des infections provoquées par de la levure et de la moisissure
US20090269394A1 (en) * 2008-04-25 2009-10-29 Nanobio Corporation Methods and compositions for treating onchomycosis
WO2009143524A2 (fr) 2008-05-23 2009-11-26 The Regents Of The University Of Michigan Vaccins à nanoémulsion
KR102080429B1 (ko) * 2008-06-26 2020-02-21 안테리오스, 인코퍼레이티드 경피 운반
EP2349209A2 (fr) 2008-09-26 2011-08-03 Nanobio Corporation Compositions thérapeutiques de nanoémulsion et procédés d'utilisation de celles-ci
EP2370057A1 (fr) * 2008-12-31 2011-10-05 Sunev Pharma Solution Limited Corporate Nouvelles formules phytosanitaires topiques pour le traitement de l'acné et des troubles cutanés
AU2010255336A1 (en) * 2009-06-05 2012-01-12 Sunev Pharma Solution Limited Topical micro-emulsions for the treatment of rheumatic disorders
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DK2343052T3 (da) 2009-12-03 2013-09-02 Novartis Ag Hydrofil filtrering under fremstilling af vaccineadjuvanter
EP2506834B1 (fr) 2009-12-03 2016-03-02 Novartis AG Circulation de constituants lors de l'homogénéisation et de la microfluidisation d'émulsions
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
AU2013213678B2 (en) * 2009-12-03 2016-06-23 Seqirus UK Limited Arranging interaction and back pressure chambers for microfluidization
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
PL2380558T5 (pl) † 2009-12-03 2020-10-05 Novartis Ag Wytwarzanie emulsji w układzie komory oddziaływań i komory przeciwciśnieniowej do mikrofluidyzacji
DE202010004750U1 (de) * 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
WO2013163176A1 (fr) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticules pour le traitement d'allergies
WO2014206857A1 (fr) * 2013-06-28 2014-12-31 Universitat Autonoma De Barcelona Formulations huile-dans-l'eau de mycobacterium et utilisations associées
CN106535632A (zh) * 2014-03-21 2017-03-22 弗罗里达大学研究基金会有限公司 用纳米颗粒和/或纳米乳液配制的醛在增强植物对黄龙病菌的疾病抗性中的用途
CN104274405A (zh) * 2014-10-21 2015-01-14 河南牧翔动物药业有限公司 一种水包油型复方头孢噻呋纳米乳抗菌药物
EP3253372B8 (fr) * 2015-02-06 2022-06-22 Woodstock Sterile Solutions, Inc. Préparation d'une émulsion huile dans l'eau pour formulations pharmaceutiques stabilisées par un polymère
EP3510161A4 (fr) 2016-08-23 2020-04-22 Akouos, Inc. Compositions et méthodes pour traiter une déficience auditive non associée à l'âge chez un sujet humain
EP3541358A1 (fr) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Administration transdermique de grands agents
CN106924730B (zh) * 2017-02-14 2019-11-08 商丘美兰生物工程有限公司 猪伪狂犬病毒芦荟胶纳米乳佐剂灭活苗及其制备方法
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
US11344484B2 (en) * 2018-01-23 2022-05-31 Conopco, Inc. Process for making transparent nanoemulsions comprising lauric oil
BR112020011757B1 (pt) * 2018-01-23 2022-03-29 Unilever Ip Holdings B.V. Nanoemulsão óleo em água
CN116096905A (zh) 2020-02-21 2023-05-09 阿库斯股份有限公司 用于治疗人受试者的非年龄相关性听力损伤的组合物和方法
CN113662006B (zh) * 2021-06-30 2022-05-20 南京凯创协同纳米技术有限公司 一种可杀灭细菌灭活病毒的微纳锌的制备方法
KR102891033B1 (ko) * 2022-06-30 2025-12-01 씨제이제일제당(주) 의료용 조성물
JP2025525354A (ja) * 2022-06-30 2025-08-05 シージェイ チェイルジェダン コーポレーション 医療用組成物
WO2024208433A1 (fr) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoémulsion sans propylène glycol
WO2024208434A1 (fr) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoémulsion sous pression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2912426B2 (ja) * 1990-06-15 1999-06-28 鐘紡株式会社 微細化エマルション組成物
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
JP4072057B2 (ja) * 2000-12-27 2008-04-02 アレス トレーディング ソシエテ アノニム ペプチド及び／またはタンパク質取り込み用の両親媒性脂質ナノ粒子
AU2002367976B2 (en) * 2001-06-05 2007-06-21 The Regents Of The University Of Michigan Nanoemulsion vaccines

Also Published As

Publication number Publication date
WO2005027872A2 (fr) 2005-03-31
WO2005027872A3 (fr) 2006-03-09
CA2528095A1 (fr) 2005-03-31
AU2004273779A2 (en) 2005-03-31
EP1633322A2 (fr) 2006-03-15
AU2004273779A1 (en) 2005-03-31
AU2004273779B2 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
WO2005027872A3 (fr) Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation
WO2008051186A3 (fr) Compositions de nano-émulsion ayant une activité anti-inflammatoire
EP2949644A3 (fr) Composés de tétracycline substituée
WO2004098494A3 (fr) Composés, compositions et procédés
MXPA02006564A (es) Composiciones antimicrobianas y metodos de uso.
WO2006047671A3 (fr) 4-aminotetracyclines et procedes d'utilisation
WO2004014893A3 (fr) Quinolones anti-microbiens, leurs compositions et utilisation
EP2345637A3 (fr) Composés de tétracycline substitués en position 3, 10 et 12a
WO2007044032A3 (fr) Préparations à effet antiviral et antibactérien important
EP2481723A3 (fr) Composés de tétracycline substitués
EP2518079A3 (fr) Inhibiteurs du VHC/VIH et leur utilisation
WO2006108075A3 (fr) Compositions et methodes accroissant la sensibilite aux medicaments et traitant les infections et maladies presentant une resistance aux medicaments
WO2006099192A3 (fr) Compositions de peroxyde organique stables
WO2005035537A3 (fr) Heterocycles tricycliques substitues et leurs utilisations
WO2008048121A3 (fr) Composés et compositions
WO2006114186A3 (fr) Suspoemulsions eau dans l'huile
WO2007005471A3 (fr) Compositions de peroxyde organique stable
WO2005051083A3 (fr) Composes molluscicides et anti-anatifes
WO2006072612A3 (fr) Triazolophthalazines
EP1938691A3 (fr) Compositions nematicides
AU2003294253A1 (en) Emulsions including surface-modified organic molecules
WO2002080855A3 (fr) Methodes et composes permettant de reduire la toxicite ou la mort cellulaire
WO2004034961A3 (fr) Antimicrobiens et leurs utilisations
GB0522412D0 (en) Fragrance compositions comprising benzo[4,5]thieno[3,2-B]pyran-2-one
WO2004105696A3 (fr) Therapie combinatoire pour le traitement des neoplasmes

Legal Events

Date Code Title Description
EEER Examination request